StockDrifts LogoStockDrifts

Sivik Global Healthcare 13F Portfolio

Portfolio Manager
Sivik Global Healthcare LLC
Performance
+6.97% (2026 Q3)
AUM (13F)
$175.04M
# of Holdings
35
Performance Rank
Allocation (Top 20)
75.2%
Latest filing
Q3 2026

Sivik Global Healthcare LLC Holdings Map

Top 35 Sivik Global Healthcare LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
XBI
SPDR SERIES TRUST
16.21%180.0K$28.4M
+20.00%(+30.00K)
2025-Q3: 250.0K shares2025-Q4: 225.0K shares2026-Q1: 150.0K shares2026-Q2: 150.0K shares2026-Q3: 180.0K shares
$98.97(+49.40%)
2026-09-30
HUM
HUMANA INC
3.86%17.7K$6.8M
-11.50%(-2.30K)
2025-Q3: 25.0K shares2025-Q4: 15.0K shares2026-Q1: 20.0K shares2026-Q2: 20.0K shares2026-Q3: 17.7K shares
$295.74(+40.32%)
2026-09-30
JNJ
JOHNSON & JOHNSON
3.63%24.0K$6.4M
+20.00%(+4.00K)
2025-Q3: 25.0K shares2025-Q4: 0 shares2026-Q1: 20.0K shares2026-Q2: 20.0K shares2026-Q3: 24.0K shares
$184.13(+37.83%)
2026-09-30
MRK
MERCK & CO INC
3.32%40.0K$5.8M
+0.00%(+0)
2025-Q3: 0 shares2025-Q4: 30.0K shares2026-Q1: 40.0K shares2026-Q2: 40.0K shares2026-Q3: 40.0K shares
$99.14(+44.88%)
2026-09-30
ABBV
ABBVIE INC
3.29%22.0K$5.8M
+46.67%(+7.00K)
2025-Q3: 20.0K shares2025-Q4: 20.0K shares2026-Q1: 15.0K shares2026-Q2: 15.0K shares2026-Q3: 22.0K shares
$209.55(+34.90%)
2026-09-30
TMO
THERMO FISHER SCIENTIFIC INC
3.28%8.5K$5.7M
+6.25%(+500)
2025-Q3: 14.0K shares2025-Q4: 12.0K shares2026-Q1: 8.0K shares2026-Q2: 8.0K shares2026-Q3: 8.5K shares
$424.11(+60.19%)
2026-09-30
CAH
CARDINAL HEALTH INC
3.18%25.0K$5.6M
+4.17%(+1.00K)
2025-Q3: 37.5K shares2025-Q4: 32.5K shares2026-Q1: 24.0K shares2026-Q2: 24.0K shares2026-Q3: 25.0K shares
$87.59(+188.46%)
2026-09-30
MCK
MCKESSON CORP
3.17%6.5K$5.5M
+62.50%(+2.50K)
2025-Q3: 7.0K shares2025-Q4: 9.0K shares2026-Q1: 4.0K shares2026-Q2: 4.0K shares2026-Q3: 6.5K shares
$589.11(+71.52%)
2026-09-30
DHR
DANAHER CORP DEL
3.16%25.0K$5.5M
+25.00%(+5.00K)
2025-Q3: 35.0K shares2025-Q4: 23.0K shares2026-Q1: 20.0K shares2026-Q2: 20.0K shares2026-Q3: 25.0K shares
$187.75(+19.54%)
2026-09-30
UNH
UNITEDHEALTH GROUP INC
3.15%15.0K$5.5M
+50.00%(+5.00K)
2025-Q3: 12.0K shares2025-Q4: 12.0K shares2026-Q1: 10.0K shares2026-Q2: 10.0K shares2026-Q3: 15.0K shares
$417.58(-2.56%)
2026-09-30

About Sivik Global Healthcare LLCโ€™s portfolio

Sivik Global Healthcare LLC reports $175.04M in US-listed equity holdings across 35 positions in its most recent 13F filing. Its largest disclosed positions are XBI (16.2%), HUM (3.9%) and JNJ (3.6%). The top 20 holdings account for 75.2% of reported assets. Its disclosed equity book has returned +61.32% on a three-year cumulative basis. Figures reflect the Q3 2026 filing.

Portfolio concentration

Portfolio concentration
XBI โ€” 16.2% ($28.38M)HUM โ€” 3.9% ($6.75M)JNJ โ€” 3.6% ($6.35M)MRK โ€” 3.3% ($5.81M)ABBV โ€” 3.3% ($5.75M)TMO โ€” 3.3% ($5.74M)CAH โ€” 3.2% ($5.56M)MCK โ€” 3.2% ($5.55M)DHR โ€” 3.2% ($5.54M)UNH โ€” 3.1% ($5.51M)Other โ€” 53.8% ($94.09M)
46%in top 10
  • XBI16.2%
  • HUM3.9%
  • JNJ3.6%
  • MRK3.3%
  • ABBV3.3%
  • TMO3.3%
  • CAH3.2%
  • MCK3.2%
  • DHR3.2%
  • UNH3.1%
  • Other53.8%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
12
CNCCENTENE CORP DEL2.8%
RVTYREVVITY INC2.6%
BRKRBRUKER CORP2.4%
MDTMEDTRONIC PLC2.2%
+8 opened
Added to
14
XBISPDR SERIES TRUST+20.0%
ELVELEVANCE HEALTH INC+180.0%
EHCENCOMPASS HEALTH CORP+166.7%
ABTABBOTT LABORATORIES+120.0%
+10 more
Trimmed
5
WATWATERS CORP-33.3%
LLYELI LILLY & CO-15.4%
HUMHUMANA INC-11.5%
BIOBIO RAD LABS INC-20.0%
+1 more

Unlock alerts, watchlists & AI chat

Sign up free to track Sivik Global Healthcare LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Sivik Global Healthcare LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1596452). View Sivik Global Healthcare LLCโ€™s 13F filings on SEC

Other funds whose largest position is XBI

Browse all

More 13F analyses

View all